CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

--On pace for largest percent decrease since March 31, 2008, when it fell 14.74% --Down 33.65% from its all-time closing high of $132.96 on June 24, 2024 --Down 30.47% from 52 weeks ago (Feb. 6, 2024) ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

We recently published a list of Top 10 Best Dividend Stocks on Robinhood. In this article, we are going to take a look at where Merck & Co., Inc.

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

In today’s edition … DNC defends Medicaid as Republicans consider cuts … 2026 Senate race in Michigan starts to take shape.

RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.

In the week since the new president took office, he’s sparked a decade’s worth of crises. But as RFK Jr. prepares to face the Senate, these four worrying health policy moves, and the chaos they’ve ...